Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis

Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD–MBD is very important in the clinic. In China, Fucoidan (FPS), a natural compound of Laminaria japoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bu-Hui, Chong, Fee-Lan, Yuan, Can-Can, Liu, Ying-Lu, Yang, Hai-Ming, Wang, Wen-Wen, Fang, Qi-Jun, Wu, Wei, Wang, Mei-Zi, Tu, Yue, Wan, Zi-Yue, Wan, Yi-Gang, Wu, Guo-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941278/
https://www.ncbi.nlm.nih.gov/pubmed/33708111
http://dx.doi.org/10.3389/fphar.2020.586725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941278/
https://www.ncbi.nlm.nih.gov/pubmed/33708111
http://dx.doi.org/10.3389/fphar.2020.586725

Ejemplares similares